title: Bosentan for digital ulcers in patients with systemic sclerosis: a prospective 3-year followup study.
authors: Niki
authors: N
authors: Tsifetaki
authors: Vassilios
authors: V
authors: Botzoris
authors: Yannis
authors: Y
authors: Alamanos
authors: Evaggelia
authors: E
authors: Argyriou
authors: Aikaterini
authors: A
authors: Zioga
authors: Alexandros A
authors: AA
authors: Drosos
mesh_terms: D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D001706:Biopsy; D000077300:Bosentan; D005260:Female; D005385:Fingers; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012595:Scleroderma, Systemic / Q000150:complications / Q000188:drug therapy*; D012867:Skin / Q000473:pathology; D012883:Skin Ulcer / Q000188:drug therapy* / Q000209:etiology; D013449:Sulfonamides / Q000627:therapeutic use*; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D013449:Sulfonamides; D000077300:Bosentan